Valo Therapeutics Oy
2768695-4ActiveDeveloping novel peptide-coated oncolytic virus immunotherapies for cancer.
Översikt
- Okänt
- Anställda
- Okänt
- Omsättning
- 2016
- Grundat
Nyckelbeslutsfattare
Marcella Origgi
Chief Executive Officer
Matti Hautsalo
Member of the Board
Lukasz Kuryk
Chief Development Officer
Andrew Dean
Member of the Board
+23 fler kontakter i Funnelfeedr
Beskrivning
Valo Therapeutics (ValoTx) is a biotechnology company spun out from the University of Helsinki, specializing in cancer immunotherapy. The organization focuses on developing novel treatments by uniquely combining oncolytic virus therapy, peptide vaccination, and viral vector approaches. Their core pr...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Okänt
- Juridisk form
- 16
- Momsnummer
- FI27686954
Beslutsfattare
27 kontakter i FunnelfeedrMarcella Origgi
Chief Executive Officer
Matti Hautsalo
Member of the Board
Lukasz Kuryk
Chief Development Officer
Andrew Dean
Member of the Board
Jeffrey Bockman
Member of the Scientific and Clinical Advisory Board
Harri Jarvelainen
Chief Operating Officer
Otto Kari
VP, Head of Antigen Business Unit
Vincenzo Cerullo
Scientific Founder and Scientific Advisor
Kevin Harrington
Member of the Scientific and Clinical Advisory Board
David Hinton
Chair of the Board
Hanne Cojoc
Head of Quality and Operations
Leena Ylösmäki
VP Preclinical Development
Eleonora Leggiero
Head of CMC and Italian Operations
Sari Pesonen
Chief Scientific Officer
Austin Smith
Medical Director
Petri Priha
VP of CMC
Charlotta Backman
VP of Clinical Operations and Regulatory Affairs
Paul Porter
Member of the Board
Malcolm K. Brenner
Member of the Scientific and Clinical Advisory Board
Paolo Antonio Ascierto
Member of the Scientific and Clinical Advisory Board
Övriga kontakter
Joseph Ndika
Senior Scientist, Antigen Analytics
Suvi Karumo
Laboratory Scientist, Antigen Business Unit
Philip Stanecki
Financial Controller
Matthew Vaughan
Communications Contact
+3 fler kontakter i Funnelfeedr
Liknande företag
20 liknande företag i FunnelfeedrSolid Immuno-Oncology Oy
Developing organ-on-chip technology for advanced cancer treatment decisions.
Sox Therapeutics AB
1 anställdaDeveloping targeted AAV gene therapies for malignant brain tumors.
AAX Biotech AB
5–9 anställdaResearch-driven biotech advancing antibody therapies via proprietary technology.
Nanohumps Biosciences Oy
Pioneering revolutionary cancer therapies using proprietary nanosized antibodies.
Oncotech Nordic AB
0 anställdaDeveloping AI diagnostics and immunotherapy to conquer global cancer.
Utforska mer
Frågor om Valo Therapeutics Oy
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo